Giorgio Mustacchi
Università degli Studi di Trieste
H-index: 24
Europe-Italy
Top articles of Giorgio Mustacchi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study | Cancers | Marina Elena Cazzaniga Paolo Pronzato Domenico Amoroso Antonio Bernardo Laura Biganzoli | 2023/12/25 |
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial | The Lancet Oncology | Lucia Del Mastro Francesca Poggio Eva Blondeaux Sabino De Placido Mario Giuliano | 2022/12/1 |
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer | Francesco Schettini Sergio Venturini Mario Giuliano Matteo Lambertini David J Pinato | 2022/12/1 | |
Anthracyclines strike back: rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer | Francesco Schettini Mario Giuliano Matteo Lambertini Rupert Bartsch David James Pinato | 2021/9/1 | |
Cost/benefit evaluations in low-middle/upper-middle income countries: biases about “out of pocket money” | Giorgio Mustacchi | 2021/5/4 | |
Abstract P2-15-14: Triple negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the … | Cancer Research | Giorgio Mustacchi Alessandra Beano Alessandra Fabi Lorenzo Livi Antonio Bernardo | 2020/2/15 |
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low-and … | Yazid Belkacemi Noemie Grellier Sahar Ghith Kamel Debbi Gabriele Coraggio | 2020/8/1 | |
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2–Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose … | Breast Care | Marina Elena Cazzaniga Claudio Verusio Mariangela Ciccarese Alberto Fumagalli Donata Sartori | 2020/2/18 |
Abstract P5-07-10: Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the … | Cancer Research | Marina Elena Cazzaniga Sabino De Placido Alessia D'Alonzo Michela Piezzo Clara Natoli | 2020/2/15 |
Co-Authors
